Movatterモバイル変換

[0]ホーム
URL:

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Molecular Psychiatry
  • Original Research Article
  • Published:

Short- and long-term effect of acetylcholinesterase inhibition on the expression and metabolism of the amyloid precursor protein

Molecular Psychiatryvolume 6, pages520–528 (2001)Cite this article

Abstract

We have investigated the acute and chronic effect of metrifonate (MTF) and dichlorvos (DDVP), respectively the prodrug and active acetylcholinesterase inhibitor, on the secretory processing of the amyloid precursor protein (APP) in SH-SY5Y neuroblastoma cells. We demonstrate that the acute treatment of SH-SY5Y cells with both compounds results in an increased secretion of the soluble fragment of APP (sAPPα) into the conditioned media of cells, with a pattern correlated to the level of acetycholinesterase inhibition. The regulation of APP processing in these conditions is mediated by an indirect cholinergic effect on muscarinic receptors, as demonstrated by inhibition with atropine. We have also followed APP expression and metabolism after long-term treatment with metrifonate. Treated cells showed reduced AChE activity after 24, 48?h and also following 7 days of repeated treatment, a time point at which increased AChE expression was detectable. At all time points sAPPα release was unaffected suggesting that enhanced sAPPα release by MTF is transitory, nevertheless the sensitivity of cholinergic receptors was unchanged, as indicated by the fact that cholinergic response can be elicited similarly in untreated and treated cells. APP gene expression was unaffected by long-term AChE inhibition suggesting that increased short-term sAPPα release does not elicit compensatory effects.

This is a preview of subscription content,access via your institution

Access options

Access through your institution

Subscribe to this journal

Receive 12 print issues and online access

￥40,000 per year

only ￥3,333 per issue

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Selkoe DJ . Amyloid beta-protein and the genetics of Alzheimer's diseaseJ Biol Chem 1996271: 18295–18298

    Article CAS  Google Scholar 

  2. Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve RL . Protease inhibitor domain encoding by an amyloid protein precursor mRNA associated with Alzheimer diseaseNature 1988331: 115–126

    Article  Google Scholar 

  3. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Greschik KHet al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptorNature 1987325: 733–736

    Article CAS  Google Scholar 

  4. Racchi M, Govoni S . Rationalizing a pharmacological intervention on the amyloid precursor protein metabolismTIPS 199920: 418–423

    CAS PubMed  Google Scholar 

  5. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf Tet al. Cleavage of amyloid β-peptide during constitutive processing of its precursorScience 1990248: 1122–1124

    Article CAS  Google Scholar 

  6. Anderson JP, Esch FS, Keim PS, Sambamurti K, Lieberburg I, Robakis NK . Exact cleavage site of Alzheimer precursor protein in neuronal PC 12 cellsNeurosci Lett 1991128: 126–128

    Article CAS  Google Scholar 

  7. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH . Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptorsScience 1992258: 304–307

    Article CAS  Google Scholar 

  8. Hung AY, Haass C, Nitsch RM, Qiu WQ, Citron M, Wurtman RJet al. Activation of protein kinase C inhibits cellular production of the amyloid beta-proteinJ Biol Chem 1993268: 22959–22962

    CAS PubMed  Google Scholar 

  9. Buxbaum JD, Koo EH, Greengard P . Protein phosphorylation inhibits production of Alzheimer amyloid βA4 peptideProc Natl Acad Sci USA 199389: 3050–3059

    Google Scholar 

  10. Wolf BA, Wertkin AM, Jolly YC, Yasuda RP, Wolfe BB, Konrad RJet al. Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid β-protein production in human neuronal NT2N cellsJ Biol Chem 1995270: 4916–4922

    Article CAS  Google Scholar 

  11. Mori F, Lai CC, Fusi F, Giacobini E . Cholinesterase inhibitors increase secretion of APPs in rat brain cortexNeuroreport 19956: 633–636

    Article CAS  Google Scholar 

  12. Giacobini E . Cholinesterase inhibitors do more than inhibit cholinesterase. In: Becker R, Giacobini E (eds).Alzheimer's Disease: From Molecular Biology to Therapy Birkhauser: Boston 1996 pp?187–204

  13. Lahiri DK, Lewis S, Farlow MR . Tacrine alters the secretion of the beta-amyloid precursor protein in cell linesJ Neurosci Res 199437: 777–787

    Article CAS  Google Scholar 

  14. Hinz VC, Grewing S, Scmitdt BH . Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvosNeurochem Res 199621: 331–337

    Article CAS  Google Scholar 

  15. Bergamaschi S, Binetti G, Govoni S, Wetsel WC, Battaini F, Trabucchi Met al. Defective phorbol ester-stimulated secretion of beta-amyloid precursor protein from Alzheimer's disease fibroblastsNeurosci Lett 1995201: 1–5

    Article CAS  Google Scholar 

  16. Ellman GI, Courtney KD, Andres VJ, Featherstone RM . A new, rapid colorimetric determination of acetylcholinesterase activityBiochem Pharmacol 19617: 88–95

    Article CAS  Google Scholar 

  17. Ehrich M . Using neuroblastoma cell lines to address differential specificity to organophosphatesClin Exp Pharmacol Physiol 199522: 291–292

    Article CAS  Google Scholar 

  18. Weidemann A, Konig G, Bunke D, Fischer P, Salbaum JM, Masters CLet al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid proteinCell 198957: 115–126

    Article CAS  Google Scholar 

  19. Ganter U, Strauss S, Jonas U, Weidemann A, Beyreuther K, Volk Bet al. Alpha 2-macroglobulin synthesis in interleukin 6 stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer beta amyloid precursor proteinFEBS Lett 1991282: 127–131

    Article CAS  Google Scholar 

  20. Knopman DS, Morris JC . An update on primary drug therapies for Alzheimer diseaseArch Neurol 199754: 1406–1409

    Article CAS  Google Scholar 

  21. Benzi G, Moretti A . Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?Eur J Pharmacol 1998346: 1–13

    Article CAS  Google Scholar 

  22. Farber SA, Nitsch RM, Schulz JG, Wurtman RJ . Regulated secretion of β-amyloid precursor protein in rat brainJ Neurosci 199515: 7442–7451

    Article CAS  Google Scholar 

  23. Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BBet al. Metrifonate benefits cognitive, behavioural, and global function in patients with Alzheimer's diseaseNeurology 199850: 1222–1230

    Article CAS  Google Scholar 

  24. Schmidt BH, Roland Heinig R . The pharmacological basis for metrifonate's favourable tolerability in the treatment of Alzheimer's diseaseDementia and Geriatric Cognitive Disorders 19989 (Suppl 2): 15–19

    Article  Google Scholar 

  25. Pakaski M, Rakonczay Z, Fakla I, Papp H, Kasa P .In vitro effects of metrifonate on neuronal amyloid precursor protein processing and protein kinase C levelBrain Res 2000863: 266–270

    Article CAS  Google Scholar 

  26. Slack BE, Breu J, Petryniak MA, Srivastava K, Wurtman RJ . Tyrosine phosphorylation-dependent stimulation of amyloid precursor protein secretion by the m3 muscarinic acetylcholine receptorJ Biol Chem 1995270: 8337–8344

    Article CAS  Google Scholar 

  27. Lahiri DK, Farlow MR, Sambamurti K . The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cellsBrain Res Mol Brain Res 199862: 131–140

    Article CAS  Google Scholar 

  28. Salvietti N, Cattaneo E, Govoni S, Racchi M . Changes in beta amyloid precursor protein secretion associated with the proliferative status of CNS derived progenitor cellsNeurosci Lett 1996212: 199–203

    Article CAS  Google Scholar 

  29. Racchi M, Johnston JA, Flood FM, Cowbum RF, Govoni S . Amyloid precursor protein metabolism in fibroblasts from individuals with one, two or three copies of the amyloid precursor protein (APP) geneBiochem J 1999338: 777–782

    Article CAS  Google Scholar 

Download references

Acknowledgements

This research was partially funded by MURST Cofin99, ‘Fondo Ateneo Ricerca’ and ‘Progetto Ateneo’ University of Pavia, Telethon E866 to SG.

Author information

Authors and Affiliations

  1. Dept of Experimental and Applied Pharmacology, University of Pavia, Italy

    M Racchi, M Sironi, A Caprera & S Govoni

  2. Pharma Research CNS, Bayer AG, Wuppertal, Germany

    G König

Authors
  1. M Racchi

    You can also search for this author inPubMed Google Scholar

  2. M Sironi

    You can also search for this author inPubMed Google Scholar

  3. A Caprera

    You can also search for this author inPubMed Google Scholar

  4. G König

    You can also search for this author inPubMed Google Scholar

  5. S Govoni

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toM Racchi.

Rights and permissions

About this article

Cite this article

Racchi, M., Sironi, M., Caprera, A.et al. Short- and long-term effect of acetylcholinesterase inhibition on the expression and metabolism of the amyloid precursor protein.Mol Psychiatry6, 520–528 (2001). https://doi.org/10.1038/sj.mp.4000878

Download citation

Keywords

Access through your institution
Buy or subscribe

Advertisement

Search

Advanced search

Quick links

[8]ページ先頭
©2009-2025 Movatter.jp